Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss.  GLP-1 medications were originally intended to ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 465.16% and ...

There is a risk too many people are being diagnosed as obese when "a more accurate" and "nuanced" definition is needed, a ...

The updated guidance, which was largely driven by lower-than-anticipated sales of GLP-1 blockbusters Mounjaro and Zepbound, ...

Heading into fiscal 2025, CEO David Ricks said the company expects sales of weight-loss drugs will continue growing, and noted that it expects "to produce at least 60% more salable doses" of the drugs ...

U.S. equities were slightly lower at midday after initially rising following the December report on producer prices.

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity and diabetes drugs.

While talk show queen Oprah Winfrey has declined to name the brand she uses, she’s among the Hollywood stars who have been ...

Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.

Therapist Debby Parker tried to lose weight for years without success. Then she discovered an online weight management ...